NFE2L2 and hepatocellular carcinoma: Notably, Nrf2-high status was significantly associated with decreased OS in HCC patients on univariate analysis (HR, 3.33; 95% CI, 1.74–6.37; p < 0.001) (Table 3, Figure 3).